Stay updated on Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial

Sign up to get notified when there's something new on the Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The study record history now shows two Results Submission Events instead of one, indicating an additional results submission event reflected in the history.
    Difference
    0.1%
    Check dated 2026-06-19T17:47:50.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The study record now shows that no participants are being sought, updating the recruitment status. A new revision tag, v3.6.0, has been added to the history to reflect an updated record version.
    Difference
    0.4%
    Check dated 2026-06-12T13:25:16.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    The record history now shows a new revision (v3.5.5) replacing the prior v3.5.4. This indicates an updated version of the study record in ClinicalTrials.gov history.
    Difference
    0.1%
    Check dated 2026-06-05T10:18:56.000Z thumbnail image
  4. Check
    43 days ago
    Change Detected
    Summary
    A new Results Submission Events (1) entry appears in the Record History, and the revision is updated from v3.5.3 to v3.5.4 to reflect the latest version of the study record.
    Difference
    0.3%
    Check dated 2026-05-15T02:16:34.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    A new revision entry v3.5.3 was added to the Record History, replacing the previous v3.5.2 entry in the revision timeline.
    Difference
    0.1%
    Check dated 2026-04-30T17:55:16.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Updated the study record history to reflect that **results were submitted** (replacing the prior state of **no results posted**), signaling the availability pipeline for trial outcomes.
    Difference
    0.1%
    Check dated 2026-04-23T14:57:05.000Z thumbnail image

Stay in the know with updates to Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Encorafenib and Binimetinib in BRAF+ Stage II Melanoma Clinical Trial page.